Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 492-498

  Bang, Casper N ^a,b   Greve, Anders M ^b   Køber, Lars ^b   Rossebø, Anne B ^d   Ray, Simon ^e   Boman, Kurt ^f   Nienaber, Christoph A ^g   Devereux, Richard B ^a   Wachtell, Kristian ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b University of Copenhagen   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UMEÅ UNIVERSITY   (Sweden)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Aortic stenosis; Hypertension; Mortality; Renin angiotensin system inhibition

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; SIMVASTATIN;

ADULT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SUDDEN CARDIAC DEATH; SYSTOLIC BLOOD PRESSURE; AGED; AORTIC VALVE STENOSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC VALVE STENOSIS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84905125983     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.013     Document Type: Article

References (31)

1. B.A. Carabello, and W.J. Paulus Aortic stenosis Lancet 373 2009 956 966
2. C.M. Otto, B.K. Lind, D.W. Kitzman, B.J. Gersh, and D.S. Siscovick Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 341 1999 142 147
3. R. Rosenhek, U. Klaar, and M. Schemper et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography Eur Heart J 25 2004 199 205
4. A.G. Greve, M. Dalsgaard, and C.N. Bang et al. Stroke in patients with aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study Stroke 7 2014 1939 1946
5. N.L. Cox, A.R. Abdul-Hamid, and G.P. Mulley Why deny ACE inhibitors to patients with aortic stenosis? Lancet 352 1998 111 112
6. M.A. Nadir, L. Wei, and D.H. Elder et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis J Am Coll Cardiol 58 2011 570 576
7. M.F. Eleid, R.A. Nishimura, P. Sorajja, and B.A. Borlaug Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction Circulation 128 2013 1349 1353
8. F. Antonini-Canterin, G. Huang, and E. Cervesato et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension 41 2003 1268 1272
9. K. Linhartova, J. Filipovsky, R. Cerbak, G. Sterbakova, I. Hanisova, and V. Beranek Severe aortic stenosis and its association with hypertension: analysis of clinical and echocardiographic parameters Blood Press 16 2007 122 128
10. K.D. O'Brien, D.M. Shavelle, and M.T. Caulfield et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 106 2002 2224 2230
11. R. Rosenhek, F. Rader, and N. Loho et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 110 2004 1291 1295
12. A. Chockalingam, S. Venkatesan, and T. Subramaniam et al. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction - Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS) Am Heart J 147 2004 E19
13. A.B. Rossebo, T.R. Pedersen, and K. Boman et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
14. A.B. Rossebo, T.R. Pedersen, and C. Allen et al. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study Am J Cardiol 99 2007 970 973
15. A.E. Rieck, D. Cramariuc, E.M. Staal, A.B. Rossebo, K. Wachtell, and E. Gerdts Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy) J Hypertens 28 2010 377 383
16. B.A. Carabello What is new in the 2006 ACC/AHA guidelines on valvular heart disease? Curr Cardiol Rep 10 2008 85 90
17. H. Baumgartner, J. Hung, and J. Bermejo et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocardiogr 10 2009 1 25
18. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
19. R.O. Bonow, B.A. Carabello, and K. Chatterjee et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
20. D.B. Rubin Estimating causal effects from large data sets using propensity scores Ann Intern Med 127 1997 757 763
21. J. Fielitz, S. Hein, and V. Mitrovic et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J Am Coll Cardiol 37 2001 1443 1449
22. N. Cote, P. Pibarot, and A. Pepin et al. Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis Int J Cardiol 145 2010 444 449
23. V. Dzau The cardiovascular continuum and renin-angiotensin-aldosterone system blockade J Hypertens Suppl 23 2005 S9 S17
24. S.G. Chrysant Angiotensin II, receptor blockers in the treatment of the cardiovascular disease continuum Clin Ther 30 Pt 2 2008 2181 2190
25. K.D. O'Brien, X.Q. Zhao, and D.M. Shavelle et al. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function J Investig Med 52 2004 185 191
26. S. Bull, M. Loudon, and J.M. Francis et al. A prospective, double-blinded, randomized trial of Ramipril in asymptomatic aortic stenosis: the RIAS trial http://eurheartj.oxfordjournals.org/content/34/suppl-1/P4717. full.pdf+html
27. W.M. Yarbrough, R. Mukherjee, J.S. Ikonomidis, M.R. Zile, and F.G. Spinale Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications J Thorac Cardiovasc Surg 143 2012 656 664
28. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
29. M. Dalsgaard, K. Iversen, and J. Kjaergaard et al. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study Am Heart J 167 2014 226 234
30. J. Jimenez-Candil, J. Bermejo, and R. Yotti et al. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study Heart 91 2005 1311 1318
31. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281